Cargando…
Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
The B-cell lymphoma 2 (Bcl-2) family, comprised of pro- and anti-apoptotic proteins, regulates the delicate balance between programmed cell death and cell survival. The Bcl-2 family is essential in the maintenance of tissue homeostasis, but also a key culprit in tumorigenesis. Anti-apoptotic Bcl-2,...
Autores principales: | Gagliardi, Maria, Ashizawa, Ana Tari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778715/ https://www.ncbi.nlm.nih.gov/pubmed/35056993 http://dx.doi.org/10.3390/pharmaceutics14010097 |
Ejemplares similares
-
The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
por: Gagliardi, Maria, et al.
Publicado: (2021) -
Nonviral delivery systems for antisense oligonucleotide therapeutics
por: Huang, Si, et al.
Publicado: (2022) -
Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides
por: Goyenvalle, Aurelie, et al.
Publicado: (2016) -
Advances in Antisense Oligonucleotide Development for Target Identification, Validation, and as Novel Therapeutics
por: Mansoor, Moizza, et al.
Publicado: (2008) -
Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells
por: Wacheck, V, et al.
Publicado: (2003)